KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 160 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $222,000 | -2.6% | 65,067 | +7.2% | 0.00% | – |
| Q2 2018 | $228,000 | -8.8% | 60,671 | -0.9% | 0.00% | – |
| Q1 2018 | $250,000 | -7.1% | 61,217 | +5.9% | 0.00% | – |
| Q4 2017 | $269,000 | -54.3% | 57,790 | -30.2% | 0.00% | – |
| Q3 2017 | $588,000 | +5.4% | 82,816 | +7.3% | 0.00% | – |
| Q2 2017 | $558,000 | +22.6% | 77,176 | +4.4% | 0.00% | – |
| Q1 2017 | $455,000 | +27.1% | 73,926 | +21.3% | 0.00% | – |
| Q4 2016 | $358,000 | +90.4% | 60,939 | +71.5% | 0.00% | – |
| Q3 2016 | $188,000 | -28.8% | 35,541 | -10.7% | 0.00% | – |
| Q2 2016 | $264,000 | +34.7% | 39,782 | -5.2% | 0.00% | – |
| Q1 2016 | $196,000 | -4.4% | 41,962 | +3.6% | 0.00% | – |
| Q4 2015 | $205,000 | +47.5% | 40,519 | +2.4% | 0.00% | – |
| Q3 2015 | $139,000 | -85.0% | 39,572 | -57.4% | 0.00% | – |
| Q2 2015 | $926,000 | -45.0% | 92,807 | -29.8% | 0.00% | – |
| Q1 2015 | $1,684,000 | +111.6% | 132,238 | +135.3% | 0.00% | – |
| Q4 2014 | $796,000 | -51.2% | 56,205 | -52.6% | 0.00% | -100.0% |
| Q3 2014 | $1,630,000 | -9.9% | 118,488 | +0.8% | 0.00% | 0.0% |
| Q2 2014 | $1,810,000 | -96.3% | 117,597 | -95.9% | 0.00% | -95.2% |
| Q1 2014 | $48,410,000 | +128.1% | 2,840,923 | +73.3% | 0.02% | +133.3% |
| Q4 2013 | $21,227,000 | +15981.1% | 1,639,165 | +12377.5% | 0.01% | – |
| Q3 2013 | $132,000 | +0.8% | 13,137 | -25.4% | 0.00% | – |
| Q2 2013 | $131,000 | – | 17,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |